Is grade 1 cervical lesion serious?

In general, doctors will classify cervical precancerous lesions according to the size and severity of the lesions. The probability of cervical precancerous lesions will also increase with the degree of disease progression. Many women go to the hospital for a series of examinations, and the doctor tells them that they are now in stage 1 cervical precancerous lesions. So, is stage 1 cervical precancerous lesions serious?

In fact, grade 1 cervical precancerous lesions are the mildest grade classification among cervical precancerous lesions. In this grade classification, many women may be cured after conditioning or treatment, but this does not mean that everyone can be cured. Therefore, although grade 1 cervical precancerous lesions are relatively mild, it is still not ruled out that the disease will further grow and progress to grade 2 or 3. There is a possibility of progressing to malignant diseases. Therefore, sick women still need to actively treat the disease to control or even cure the disease to avoid serious consequences.

In addition, women with cervical precancerous lesions must go to the hospital for examination on time within the required time to have a deeper understanding of the symptoms to avoid further malignancy and responsibility for their own bodies and families.

Cervical intraepithelial neoplasia is a cervical disease that is closely related to cervical cancer and often occurs in women between 25 and 35 years old. Most low-grade CIN can disappear naturally, but high-grade CIN has the potential to cause disease.

Factors related to cervical intraepithelial neoplasia include HPV infection, multiple sexual partners, first sexual intercourse before the age of 16, early childbearing, multiple births and smoking, which are associated with the occurrence of CIN.

Cervical intraepithelial neoplasia is divided into grade one, grade two, and grade three. About 60% of CIN grade 1 can disappear naturally due to slight dysplasia. If the cytology examination is LSIL or below, it can be observed and followed up. If during the follow-up process, the disease progression or persistence lasts for 2 years, treatment should be carried out.